rs12914333

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_033028.5(BBS4):​c.906T>C​(p.Phe302Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.993 in 1,614,126 control chromosomes in the GnomAD database, including 796,409 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.96 ( 70705 hom., cov: 32)
Exomes 𝑓: 1.0 ( 725704 hom. )

Consequence

BBS4
NM_033028.5 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.328

Publications

22 publications found
Variant links:
Genes affected
BBS4 (HGNC:969): (Bardet-Biedl syndrome 4) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse. The similar phenotypes exhibited by mutations in BBS gene family members are likely due to the protein's shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene has sequence similarity to O-linked N-acetylglucosamine (O-GlcNAc) transferases in plants and archaebacteria and in human forms a multi-protein "BBSome" complex with seven other BBS proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
BBS4 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • BBS4-related ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_033028.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 15-72731596-T-C is Benign according to our data. Variant chr15-72731596-T-C is described in ClinVar as Benign. ClinVar VariationId is 166734.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.328 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033028.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS4
NM_033028.5
MANE Select
c.906T>Cp.Phe302Phe
synonymous
Exon 12 of 16NP_149017.2
BBS4
NM_001320665.2
c.837T>Cp.Phe279Phe
synonymous
Exon 11 of 15NP_001307594.1H3BSL2
BBS4
NM_001252678.2
c.390T>Cp.Phe130Phe
synonymous
Exon 11 of 15NP_001239607.1Q96RK4-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS4
ENST00000268057.9
TSL:1 MANE Select
c.906T>Cp.Phe302Phe
synonymous
Exon 12 of 16ENSP00000268057.4Q96RK4-1
BBS4
ENST00000395205.7
TSL:1
c.390T>Cp.Phe130Phe
synonymous
Exon 11 of 15ENSP00000378631.3Q96RK4-3
BBS4
ENST00000566400.6
TSL:1
c.390T>Cp.Phe130Phe
synonymous
Exon 11 of 15ENSP00000456759.2H3BSL3

Frequencies

GnomAD3 genomes
AF:
0.962
AC:
146326
AN:
152120
Hom.:
70658
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.866
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.989
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.994
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.978
GnomAD2 exomes
AF:
0.990
AC:
248949
AN:
251492
AF XY:
0.993
show subpopulations
Gnomad AFR exome
AF:
0.859
Gnomad AMR exome
AF:
0.994
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.997
GnomAD4 exome
AF:
0.996
AC:
1456323
AN:
1461888
Hom.:
725704
Cov.:
80
AF XY:
0.997
AC XY:
724932
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.864
AC:
28917
AN:
33478
American (AMR)
AF:
0.994
AC:
44443
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26136
AN:
26136
East Asian (EAS)
AF:
1.00
AC:
39700
AN:
39700
South Asian (SAS)
AF:
1.00
AC:
86233
AN:
86258
European-Finnish (FIN)
AF:
1.00
AC:
53417
AN:
53418
Middle Eastern (MID)
AF:
0.994
AC:
5732
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111840
AN:
1112010
Other (OTH)
AF:
0.992
AC:
59905
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
362
724
1086
1448
1810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21668
43336
65004
86672
108340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.962
AC:
146431
AN:
152238
Hom.:
70705
Cov.:
32
AF XY:
0.963
AC XY:
71719
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.866
AC:
35923
AN:
41492
American (AMR)
AF:
0.989
AC:
15139
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5174
AN:
5174
South Asian (SAS)
AF:
1.00
AC:
4818
AN:
4820
European-Finnish (FIN)
AF:
1.00
AC:
10612
AN:
10612
Middle Eastern (MID)
AF:
0.993
AC:
292
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68022
AN:
68046
Other (OTH)
AF:
0.979
AC:
2067
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
243
485
728
970
1213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.986
Hom.:
101664
Bravo
AF:
0.956
Asia WGS
AF:
0.993
AC:
3453
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
1.00

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
1
Bardet-Biedl syndrome (1)
-
-
1
Bardet-Biedl syndrome 4 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
3.3
DANN
Benign
0.61
PhyloP100
0.33
PromoterAI
0.013
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs12914333;
hg19: chr15-73023937;
COSMIC: COSV108037467;
COSMIC: COSV108037467;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.